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ABSTRACT
Introduction: Insights into molecular karyotyping using comparative genomic hybridization (CGH) and single nucle-
otide polymorphism (SNP) arrays enable the identification of copy number variations (CNVs) at a higher resolution 
and facilitate the detection of copy neutral loss of heterozygosity (CN-LOH) otherwise undetectable by conventional 
cytogenetics. The applicability of a customised CGH+SNP 180K DNA microarray in the diagnostic evaluation of 
Acute Myeloid Leukaemia (AML) in comparison with conventional karyotyping was assessed in this study. Methods: 
Paired tumour and germline post induction (remission sample obtained from the same patient after induction) DNA 
were used to delineate germline variants in 41 AML samples and compared with the karyotype findings. Results: 
After comparing the tumour versus germline DNA, a total of 55 imbalances (n 5-10 MB = 21, n 10-20 MB = 8 and 
n >20 MB = 26) were identified. Gains were most common in chromosome 4 (26.7%) whereas losses were most 
frequent in chromosome 7 (28.6%) and X (25.0%). CN-LOH was mostly seen in chromosome 4 (75.0%). Compar-
ison between array CGH+SNP and karyotyping revealed 20 cases were in excellent agreement and 13 cases did 
not concord whereas in 15 cases finding could not be confirmed as no karyotypes available. Conclusion: The use 
of a combined array CGH+SNP in this study enabled the detection of somatic and germline CNVs and CN-LOHs in 
AML. Array CGH+SNP accurately determined chromosomal breakpoints compared to conventional cytogenetics in 
relation to presence of CNVs and CN-LOHs. 
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INTRODUCTION
Acute myeloid leukaemia (AML) is a heterogeneous 
malignant haematopoietic disorder that is characterized 
by an increase in immature myeloid cells. It is a result 
of an arrest of normal cell differentiation in the bone 
marrow. AML is also known as a disease marked by 
heterogeneity in diagnosis, classification, response to 
therapy and survival. Recent insights into the genomic 
landscapes of AML have led to tremendous advancement 
in understanding the molecular pathogenesis of this 
disease. Currently, the state-of-the-art in the diagnosis 
of AML relies on the integration of clinicopathological 
findings which include morphologic assessment, 
immunophenotypic analysis, and genetic studies.
The advent of molecular cytogenetics using comparative 
genomic hybridization (CGH) and a similar microarray 
analysis of single nucleotide polymorphism (SNP) has 
permitted comprehensive genome-wide assessments 
at resolutions higher than conventional cytogenetics. 
Molecular karyotyping enables the elucidation of 
genetic alterations that may have a significant role 
in the pathogenesis of AML and could lead to better 
stratification of diagnosis and prognosis. In terms 
of resolution, molecular karyotyping allows the 
detection of genomic lesions of ~ 400 kb in size, thus 
surpassing conventional cytogenetics (3-5 Mb) (1). 
Microarray platforms utilises customised probes that are 
designed down to a single exon resolution permitting 
detection of submicroscopic genetic lesions including 
microduplications and microdeletions that may be 
clinically relevant. Moreover, all DNA, tumour and non-
tumour is represented and so there is no selection or bias. 
Besides copy number variations (CNVs), SNP – array 
facilitates the detection of uniparental disomy (UPD), 
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undetectable by conventional cytogenetics which are 
unable to detect copy neutral loss of heterozygosity 
(CN-LOH) (2-6).
Therefore, molecular karyotyping using a combination 
of CGH+SNP DNA microarray can complement 
conventional cytogenetics not only in the diagnosis but 
also in the classification and prognostication of AML. 
In addition, the discovery of cryptic chromosomal 
aberrations and novel disease related genomic regions 
is possible through the utilisation of CGH+SNP DNA 
microarray in a clinical setting. The present investigation 
identifies somatically-acquired genetic aberrations in 
AML by using CGH+SNP DNA microarray and compares 
the findings with karyotyping. 
MATERIALS AND METHODS
Subject Recruitment and Selection
This cross-sectional study was performed on AML 
subjects (n=41) diagnosed and treated at Haematology 
Department, Hospital Ampang and Medical Department, 
Hospital Sultanah Aminah, Johor Baru over a period 
of 14 months (July 2013 till September 2014).  Only 
cases with paired remission samples were included to 
facilitate determination of somatic aberrations. All cases 
were diagnosed by incorporating clinical and laboratory 
information which included morphologic assessment, 
flow cytometry immunophenotyping, conventional 
cytogenetics and molecular studies based on WHO 
Classification (2008) (7).  Subjects of this study include 
18 males (aged between 21 and 77 years with median 
of 54) and 23 females (aged between 14 and 71 years 
with median of 52). All samples were collected upon 
patient’s informed consent during this study period. 
The Medical Research Ethics Committee of the Ministry 
of Health Malaysia approved this study (NMRR-12-
844-12051) alongside the Research Ethics Committee 
Universiti Putra Malaysia (FPSK [EX14] P037). 
DNA Extraction
DNA was extracted from bone marrow aspirates and 
peripheral blood samples using QIAamp® DNA Mini and 
Blood Mini Kit. Agilent Male and Female reference DNA 
supplied with the SureTag Complete DNA Labelling Kit 
were used as reference. The Agilent reference DNA used 
in this study were well characterised CNVs and CN-
LOHs derived single individual normal male and female 
individuals of Caucasian ethnicity. Sample quantity and 
quality were assessed by UV-VIS Spectrophotometry 
(NanoDrop ND-1000), gel electrophoresis (2200 
TapeStation) and Fluorometer (Qubit 2.0).
Custom Agilent SurePrint G3 CGH+SNP 180K Design
All samples were processed using custom Agilent 
SurePrint G3 CGH+SNP 180K (Agilent Technologies, 
Santa Clara, USA). This custom chip was designed 
in November 2013 based on Cancer Cytogenomics 
Microarray Consortium (CCMC) design and Human 
Genome 19 (Hg19), distributed by University of 
California, Santa Cruz (UCSC) genome browser (this 
build is derived from Genome Reference Consortium 37 
(GRCh37) prepared by Genome Reference Consortium. 
This platform allowed simultaneous detection of CNVs 
and CN-LOHs. Resolution of the SNP array ranged 
between 5 to 10 Mb. Additional custom probes for 47 
genes were added to array with eleven genes covering 
every exon (TP53, DNMT3A, TET2, ASXL1, MLL, IKZF1, 
PAX5, EZH2, FLT3, NOTCH1 and ATM). The coverage 
of probes for the exon resolution gene is between 5-7 
probes/exon.  The other 36 genes are as follow: CEBPA, 
FHIT, ETV6, CBFB, NF1, MYC, ET52, RUNX1, RB1, 
CDKN2A, CCND1, PDGFRA, PDGRFB, FGFR1,ABL1, 
BCOR, BCORL1, BRAF,CBL, CCND3, EZH2, FAM5C, 
FBXW7, GATA1, HNRNPK, ID3, IDH1, IDH2, JAK2, 
KDM6A, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN1, 
RAD21, SETBP1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, 
U2AF1, WT1, and ZRSR1. 
Array CGH+SNP experiment was carried out based on 
the protocol provided by the manufacturer. Genomic 
DNA was subjected to restriction digestion using AluI 
and RsaI restriction enzymes which overlap with known 
SNP sites.  Completeness of digestion was assessed 
before sample labelling by using DNA 1000 assay kit 
on Agilent 2100 Bioanalyzer. Array CGH required a 
two colour labelling protocol where the sample was 
labelled with Cy5 and gender matched Agilent’s Human 
Reference DNA Male or Female was labelled with Cy3. 
Random primers and the exo-Klenow fragment were 
used to differentially label gDNA with fluorescent-
labelled nucleotides. Nanodrop 2000 UV-VIS was 
used to analyse DNA yield, specific activity and degree 
of labelling before the sample and matched reference 
DNA were combined, followed by hybridization in the 
presence of Cot-1 DNA (Agilent Technologies, Santa 
Clara, USA) at 67°C for 24 hours. By utilizing Agilent 
microarray scanner, the slides were scanned at 3µm 
resolution followed by image processing via Agilent 
Feature Extraction Software version 12.0.0.7. 
Array CGH+SNP Data Analysis
Analysis was integrated with Cytogenomics software 
version 2.9.2.4. Mosaic analysis method was selected 
for all sample analysis with an Aberration Detection 
Method-2 (ADM-2) algorithm, threshold set at 6.0, 
Fuzzy Zero switched off and GC correction setting was 
switched on. Result analysis was based on genome 
build Hg19. 
We used Agilent reference DNA (male and female) 
derived from Caucasian population in this study as these 
reference DNAs are genotyped and well characterized by 
the manufacturer. To reduce the bias in the comparison 
of CNVs and CN-LOHs in Caucasian versus Malaysian 
genome, we have utilised a customised Malaysian 
normal recurrent CNVs customised genome track 
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created by Clinical Haematology Referral Laboratory, 
Hospital Ampang. This customised genome track are 
well characterised based on gender and ethnicity of 
Malaysians (10).
Paired Tumour and Germline DNA Analyses
Paired tumour and germline (post induction remission 
sample obtained from the same patient) DNA were used 
to delineate germline variants. Tumour and matched 
germline DNA aberrations and LOH intervals reports 
generated by Cytogenomics software version 2.9.2.4 
were compared for all cases. Matching aberrations 
present in tumour and matched germline DNA were 
considered germline and changes present only in tumour 
were classified as tumour related changes. 
In this study, apart from using SNP probes to detect the 
presence of CN-LOH, we used these probes to confirm 
the CGH probe findings in detection of chromosomal 
gains and deletion (CNVs). Hence, we focussed on 
aberrations above 5 Mb to match the resolution limit 
of SNP probes with the array CGH probes.  Aberrations 
were then grouped according to sizes: less than one Mb, 
one to five Mb, five to ten Mb, 10 - 20 Mb, and larger 
than 20 Mb (8). 
Exclusion of Germline Lesions for International System 
for Human Cytogenetic Nomenclature (ISCN), 2013
Karyotypes were retrieved (if available) and compared 
with array CGH+SNP findings. Data before and after 
exclusion of germline CNVs and SNPs were generated 
for each case to illustrate somatic nature of these lesions. 
Germline CNVs and SNPs were suppressed manually 
in the Cytogenomics software version 2.9.2.4 before 
generating ISCN, 2013 nomenclature for all the samples 
(9). This was to ensure the final data only represents the 
tumour related aberrations present in each sample.
Statistical Analyses
Classification of type of aberrations, grouping of 
aberrations based on sizes, location and coordinates 
were performed using Statistical Package of Social 
Science (SPSS) version 20 (SPSS Inc., Chicago, IL, USA). 
RESULTS
Paired tumour and germline DNA analysis
After comparing tumour DNA versus germline DNA, a 
total of 55 imbalances (n 5-10 Mb = 21, n 10-20 Mb 
= 8 and n >20 Mb = 26) were identified. Regions with 
aberrations above 20 Mb were mostly losses (n=9 regions) 
whereas regions with smaller aberrations of 5-10 Mb 
were CN-LOH (n=9).  Twenty eight regions with losses, 
15 regions with gains and CN-LOH in 12 regions were 
detected. The most commonly gained chromosome was 
4 (26.7%) whereas losses were frequent in chromosome 
7 (28.6%) and X (25.0%). CN-LOH was mostly seen in 
chromosome 4 (75.0%). In chromosome 4, gains were 
seen in the p and q arms whereas in X chromosomes, 
losses of p and q arms were identified as the recurrent 
aberration in our cases series as shown in Table I 
Germline Only Genomic Aberrations
Apart from identifying tumour specific genomic regions, 
we identified 23 genomic imbalances which were only 
seen in germline DNA (n 5-10 Mb = 14, n 10-20 Mb 
=3 and n >20 Mb = 6).  Of these about 87 % were 
CN-LOH (n 5-10 Mb = 11, n 10-20 Mb = 3 and n >20 
Mb = 6). However, there was no recurrent aberration 
seen in the germline samples. We have compared 
the germline CNVs identified in this study with a 
customised Malaysian normal recurrent CNVs and CN-
LOH track established by Clinical Haematology Referral 
Laboratory Hospital Ampang which was established 
using 48 healthy and normal Malaysian adults (10). List 
of chromosomes, cytobands, coordinates and types of 
aberrations are summarized in Table II.
Exclusion of Germline Lesions in the CGH+SNP Analysis
Summary of the CGH+SNP results before and after 
exclusion of germline lesions based on International 
System for Human Cytogenetic Nomenclature (ISCN), 
Table I: Recurrent genomic aberrations detected in tumour
Chromosome Cytoband Size (Mb) Start Stop Aberration Type
4 p16.3 - p11 49.492586 12,440 49,505,025 Gain
4 p16.3 - p11 49.523083 12,440 49,535,522 Gain
4 q11 - q35.2 137.79361 52,672,433 190,466,045 Gain
4 q11 - q35.2 138.20208 52,672,433 190,874,516 Gain
X p22.33 - p11.1 55.551544 2,695,374 58,246,917 Loss
X p22.33 - p11.1 55.84845 2,695,374 58,543,823 Loss
X p22.33 - p11.1 55.84845 2,695,374 58,543,823 Loss
X q11.1 - q28 93.1679 61,934,507 155,102,406 Loss
X q11.1 - q28 93.1679 61,934,507 155,102,406 Loss
X q11.1 - q28 93.320806 61,781,601 155,102,406 Loss
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2013 as listed in Table III (9). 
Comparison of CGH+SNP Analysis and Karyotyping
CGH+SNP results were compared with the conventional 
karyotyping results when available. Out of 41 cases, 
karyotyping results were normal in 17 cases, 9 cases 
showed structural aberrations, 7 cases had no analysable 
chromosome spreads and in 8 cases, karyotypes 
were not available. Excellent agreements between 
the karyotype and CGH+SNP results were observed 
in 20 cases, with CGH+SNP providing more precise 
breakpoint definition. In 13 cases karyotypes were not 
in agreement with CGH+SNP results; in 4 cases with 
normal karyotype, regions of CN-LOH were detected 
(S05,S09,S24,S26)  and in another 3 cases array 
CGH+SNP detected aberrations which was missed by 
conventional karyotyping (S03,S31,S36). As expected, 
translocations were not detected by CGH+SNP in 6 
cases.  The array findings could not be confirmed in 15 
cases (7 cases with no analysable chromosome spread 
by karyotyping and 8 cases with no results available). 
Table IV summarises CGH+SNP findings and subjects 
with abnormal karyotype.
DISCUSSION
Table II: Germline only genomic aberrations with cytoband, size, and coordinate
Chromosome Cytoband Size (Mb) Start Stop Aberration Type
1 p31.3 - p31.1 6.019609 68,886,499 74,906,107 CN-LOH
1 q32.1 - q42.2 27.140594 205,441,074 232,581,667 CN-LOH
3 p14.2 - p13 11.357126 62,820,908 74,178,033 CN-LOH
3 q26.31 - q27.2 9.1492 175,384,006 184,533,205 CN-LOH
4 q21.1 - q32.1 81.924655 78,345,009 160,269,663 CN-LOH
4 q22.1 - q22.3 6.663701 91,297,445 97,961,145 CN-LOH
5 p15.2 - p14.3 10.975143 9,992,043 20,967,185 CN-LOH
6 q22.32 - q23.3 10.210033 126,895,368 137,105,400 CN-LOH
10 q22.3 - q24.33 27.418842 78,194,812 105,613,653 CN-LOH
10 q11.21 - q11.23 5.035224 45,904,882 50,940,105 Loss
11 q22.3 5.000256 103,948,375 108,948,630 CN-LOH
12 q21.31 - q21.33 5.306067 84,392,856 89,698,922 CN-LOH
12 q24.11 - q24.33 20.063904 109,937,907 130,001,810 CN-LOH
13 q14.3 - q21.2 5.448647 54,411,259 59,859,905 CN-LOH
14 q12 - q22.2 25.950688 29,504,400 55,455,087 CN-LOH
14 q21.2 - q22.1 6.106469 45,046,941 51,153,409 CN-LOH
15 q15.1 - q21.1 6.166393 41,069,619 47,236,011 CN-LOH
16 q21 5.277076 60,292,273 65,569,348 Gain
16 q23.3 - q24.3 5.055068 83,847,630 88,902,697 Loss
17 p13.1 - p11.2 7.496026 9,865,311 17,361,336 CN-LOH
17 q22 - q23.2 6.364245 53,010,381 59,374,625 CN-LOH
17 q22 - q24.1 6.655919 57,263,393 63,919,311 CN-LOH
18 q21.31 - q23 22.989711 54,989,859 77,979,569 CN-LOH
21 q11.2 - q22.2 26.932082 14,458,104 41,390,185 Gain
21 q21.3 - q22.12 7.403755 30,255,817 37,659,571 Gain
21 q22.2 - q22.3 6.6613 41,429,018 48,090,317 Loss
Within 49% of the cases, the results of karyotype 
and CGH+SNP analysis were observed to be in 
concordance. Moreover, CGH+SNP analysis provided 
accurate breakpoint size and involved genes within 
chromosomal analysis. In 32% of the cases, however, 
karyotype findings did not match results of CGH+SNP 
analysis. Out of these cases, three cases (S03,S31,S36), 
displayed erroneous karyotypes due to failure to map 
the exact location of abnormalities and one of the cases 
showcased a complex karyotype. Additionally, four 
cases with normal-karyotype revealed CN-LOH regions 
available through CGH+SNP analysis, which would not 
be detectable using conventional cytogenetics methods. 
As expected, translocations seen in 6 cases were not 
detected by CGH+SNP analysis. CGH+SNP analysis 
also discovered chromosomal aberrations in five out 
of seven cases whereby analysable spreads were not 
available through conventional karyotyping means. 
We have included cases with no karyotypes in this study 
as to reveal the benefits of array CGH+SNP in cases 
where no karyotypes are available due to technical 
and sampling reasons. Significant limitations are faced 
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Table III: CGH+SNP results before and after exclusion of germline lesions based on ISCN (2013)
Subject ID Before Germline Exclusion After Germline Exclusion
S01 arr Xp22.33(63,303-2,348,740)x1,Xq11.1q28(61,781,601-155,232,877)x1,Yp11.32p11.2(13,303-10,084,438)
x1,Yq11.1q12(13,135,703-59,335,883)x1,2p23.3(25,456,917-25,537,174)x2,2p12p11.2(76,134,547-84,198,744)
x2,2p11.2(89,185,302-89,319,978)x3,4q12q13.1(56,670,475-65,652,347)x2,4q27(121,348,002-121,533,345)x1,4q3
4.2q35.1(177,489,679-183,315,577)x2,6q15q16.1(91,670,945-97,101,702)x2,7p12.1p11.2(51,568,969-54,972,575)
x2,8p23.1(7,239,491-7,779,266)x1,9q34.3(139,393,369-139,418,283)x2,10q11.22(46,938,469-47,717,349)x1,1
0q26.13(124,347,870-124,351,275)x2,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)x3,
15q11.1q13.1(20,399,030-28,377,123)x2,16p13.11(16,364,101-16,772,356)x1,16p11.2p11.1(31,735,156-35,257,727)
x2,16q21(60,107,797-65,919,653)x2,16q24.3(89,809,755-90,088,436)x2,17p13.1(7,572,822-7,590,998)x2,18p11.3
1p11.23(5,607,798-7,759,400)x2
arr(1-22)x2,(XY)x1
S02 arr Xp22.33p22.32(91,932-5,441,039)x2,2p23.3(25,457,245-25,497,999)x2,2p11.2(89,141,608-89,319,978)
x4,8p22(15,952,011-16,021,744)x3,8p11.22(39,258,894-39,381,514)x10,8q23.3(116,493,571-117,094,928)x1,9p13.
1p11.2(38,812,449-46,953,126)x2,14q32.33(106,331,956-106,943,374)x3,14q32.33(106,469,365-106,513,022)x3,1
5q11.1q11.2(20,399,030-22,586,951)x4,17q11.2(29,546,107-29,562,744)x3,17q21.33(48,262,645-48,275,584)x2,2
2q11.22(23,056,562-23,244,636)x9
arr(1-22,X)x2
S03 arr Xp22.33(63,303-1,945,721)x2,Xp11.23(48,525,493-48,658,937)x3,2p23.3(25,456,917-25,537,174)
x2,2p16.3(49,231,108-52,519,423)x2,2p11.2(89,141,608-89,319,978)x5,2p11.2p11.1(89,538,815-92,184,540)
x2,4q13.2(70,108,664-70,223,408)x1,4q28.3(138,123,923-138,261,712)x1,4q34.3q35.1(177,998,382-183,337,339)
x2,7p12.1p11.2(51,376,150-54,742,296)x2,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,8
q11.21q11.23(50,806,102-53,436,068)x2 hmz,8q24.3(145,532,050-145,897,770)x2,9p11.2(44,318,661-45,036,533)
x3,9q34.3(139,390,541-139,418,283)x2,11p12(38,035,794-42,125,623)x2,14q21.2q21.3(45,979,670-48,518,396)x2,
14q32.33(106,037,979-106,239,525)x3,14q32.33(106,331,956-106,561,182)x3,14q32.33(106,375,298-106,449,894)
x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,566,837-106,943,374)x3,15q14(34,695,166-34,841,446)
x1,16p11.2(32,015,694-34,363,720)x2,17p13.1(7,572,822-7,590,998)x2,17q21.33(48,263,136-48,275,584)x2,1
7q25.3(79,047,509-79,975,300)x2,22q11.21(19,707,321-19,716,812)x2,22q11.22(23,056,562-23,244,636)x10
arr 7p22.3p11.2(58,764-56,935,608)x3,7q
11.21q36.3(63,374,309-158,943,158)x1
S04 arr 1q21.1(144,950,149-145,081,881)x2,2p11.2(89,141,608-89,319,978)x3,5p13.3(29,327,285-29,562,431)
x4,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,9p13.1p11.2(39,058,058-47,212,321)x2,1
4q32.33(106,331,956-106,544,481)x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,636,701-106,943,374)x3,15
q11.1q11.2(20,055,137-22,698,581)x3,22q11.22(23,056,562-23,244,636)x9
arr(1-22,X)x2
S05 arr Xp22.33(63,303-2,865,335)x2,Xp11.4(38,577,856-40,329,863)x1,2p23.3(25,456,917-25,537,174)x2,2p
12p11.2(77,020,973-83,975,111)x2,2p11.2(89,141,608-89,319,978)x4,4q12q13.2(58,661,978-66,853,487)
x2,8p22(15,952,011-16,021,744)x3,8p11.22(39,258,894-39,381,514)x10,8q23.2q23.3(111,730,471-114,131,155)x2,
9p13.1p11.2(38,459,475-47,212,321)x2,9q34.3(139,389,744-139,418,283)x2,10q26.13(124,314,524-124,395,668)x2
,13q14.3q21.33(53,755,412-71,903,342)x2,14q11.2(19,376,762-20,421,677)x3,14q32.33(106,331,956-106,552,084)
x3,14q32.33(106,469,365-106,497,204)x3,14q32.33(106,636,701-106,943,374)x4,16q21(60,292,273-65,569,348)
x2,17p13.1(7,572,822-7,590,998)x2,17q22q24.1(57,455,620-63,176,847)x2 hmz,19p13.3(502,228-1,656,386)x2,2
2q11.1(16,114,195-16,434,984)x3,22q11.22(23,056,562-23,244,636)x10
arr 17q22q24.1(57,455,620-63,176,847)
x2 hmz
S06 arr Xp22.33(63,303-2,656,392)x2,Xq27.2(140,673,376-140,738,473)x1,2p23.3(25,456,917-25,537,174)
x2,2p11.2(89,141,608-89,319,978)x4,4p14(38,774,784-40,746,231)x2,4q12q13.2(58,415,025-67,199,889)
x2,5q32(149,433,880-149,516,292)x2,7q11.23(73,396,886-73,481,111)x2,8p22(15,952,011-16,021,744)x4,
8p11.22(39,258,894-39,381,514)x10,8q24.3(145,737,350-145,743,935)x2,9p22.1p21.3(18,847,288-22,472,338)x2 hm
z,9p22.1p21.3(19,600,306-22,347,561)x1,9p13.2(36,838,638-37,015,082)x2,9p13.1p11.2(39,167,334-45,783,387)x2
,9q34.3(139,390,541-139,438,547)x2,10q26.13(124,291,833-124,396,755)x2,14q11.2(19,572,252-20,421,677)x2,1
4q11.2(22,571,278-23,421,023)x2,14q13.1q13.3(34,857,622-36,600,754)x2,14q32.33(105,052,722-106,243,254)x2,
14q32.33(106,331,956-106,526,266)x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,636,701-106,943,374)
x4,15q11.2(22,000,090-22,698,581)x2,16p13.3(2,103,321-2,138,687)x2,16p11.2(32,573,808-34,384,670)
x2,16q21(60,211,425-65,545,445)x2,17p11.2p11.1(21,546,572-22,203,007)x3,17q21.33(48,263,136-48,275,584)x2,2
2q11.21(19,707,321-19,721,668)x2,22q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S07 arr 1p36.13(16,833,957-17,241,809)x2,2p25.3(63,431-386,519)x3,2p23.3(25,457,245-25,537,174)
x2,2p11.2(89,141,608-89,319,978)x4,2p11.2p11.1(89,538,815-92,273,822)x2,5p14.3p14.1(19,877,286-24,646,268)
x2 hmz,8p23.1(7,239,491-7,779,266)x3,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,9p
13.1p11.2(39,058,058-47,212,321)x2,9q34.3(139,390,541-139,440,753)x2,11p12(36,736,289-39,968,503)x2 hmz
,12p11.1(33,465,932-33,822,244)x3,14q11.2(19,376,762-20,421,677)x3,14q32.33(106,331,956-106,552,084)x3,1
4q32.33(106,469,365-106,513,022)x3,14q32.33(106,636,701-106,943,374)x4,15q11.1q11.2(20,399,030-22,297,110)
x3,16p11.2(32,015,694-34,427,859)x2,17q21.33(48,263,136-48,275,584)x2,22q11.21(18,661,724-18,889,098)x1,2
2q11.22(23,056,562-23,244,636)x10,22q11.23(25,672,585-25,892,401)x1
arr(1-22)x2,(XY)x1
S08 arr Xp22.33(145,768-2,591,200)x2,2p23.3(25,458,523-25,537,174)x2,2p11.2(89,141,608-89,319,978)
x4,4p16.3p11(12,440-49,505,025)x3,4q11q35.2(52,672,433-190,466,045)x3,5q23.1(121,034,626-121,315,329)
x1,8p23.3p11.1(194,625-43,727,674)x3,8p23.1(7,303,187-7,779,266)x3,8p22(15,952,011-16,021,744)x3,8p11.2
2p11.1(39,189,481-43,520,355)x2 hmz,8p11.22(39,258,894-39,381,514)x3,8q11.1q24.3(46,924,418-146,293,435)x3,8q1
1.1q11.21(47,763,671-51,191,546)x2 hmz,9p13.1p11.2(39,167,334-47,212,321)x3,9q12q21.11(65,632,517-71,016,040)
x3,9q34.3(139,390,541-139,418,283)x3,14q11.2(19,434,575-20,143,830)x3,14q32.33(106,331,956-106,943,374)x3
,14q32.33(106,469,365-106,497,204)x3,16p11.2(32,015,694-34,427,859)x2,17q21.33(48,264,131-48,276,293)x2,2
1q21.3(29,011,058-29,281,955)x1,22q11.22(23,056,562-23,244,636)x10
arr 4p16.3p11(12,440-49,505,025)x3,4q
11q35.2(52,672,433-190,466,045)x3,8p
23.3p11.1(194,625-43,727,674)x3,8q11.
1q24.3(46,924,418-146,293,435)x3
S09 arr Xp22.33(145,768-888,218)x2,Xp11.3(43,599,360-44,036,619)x3,2p23.3(25,457,245-25,537,174)
x2,2p11.2(89,141,608-89,319,978)x4,2p11.2p11.1(89,538,815-92,273,822)x2,3p12.1p11.1(87,074,534-90,064,515)
x2 hmz,3q11.2(93,989,454-94,298,117)x2 hmz,7p14.1(38,295,198-38,382,567)x2,7q11.23(73,449,704-73,481,111)
x2,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,8q11.21q11.23(50,060,960-53,880,247)x2 
hmz,9p11.2(44,318,661-45,036,533)x3,9q34.3(139,390,541-139,418,283)x3,10q26.13(124,347,870-124,351,275)x5
,12q13.2q14.1(56,069,231-61,972,806)x2 hmz,13q21.1(57,760,470-57,913,415)x1,14q11.2(19,572,252-20,421,677)
x3,14q11.2(22,436,040-23,011,311)x2,14q32.33(106,331,956-106,552,084)x3,14q32.33(106,469,365-106,497,204)x3
,14q32.33(106,636,701-106,943,374)x3,15q11.1q11.2(20,481,702-22,698,581)x3,17q21.33(48,263,136-48,277,213)
x2,19p13.3(1,206,486-1,656,386)x2,21q11.2q21.1(15,580,827-18,422,045)x2 hmz,22q11.1(16,054,691-16,434,984)
x3,22q11.21(18,661,724-18,889,098)x1,22q11.21(19,707,321-19,721,668)x3,22q11.22(23,056,562-23,244,636)x10,2
2q12.1(28,193,727-28,196,474)x3
arr 12q13.2q14.1(56,069,231-61,972,806)
x2 hmz
S10 arr Xp22.33(145,768-2,390,502)x1,Yp11.32p11.2(95,768-10,045,809)x1,Yq11.223q11.23(24,108,372-27,617,606)
x1,1q31.1(189,331,252-189,535,626)x1,1q43(237,633,579-240,599,264)x2,2p23.3(25,458,440-25,537,174)
x2,2p11.2(89,185,302-89,319,978)x4,8p23.1(7,239,491-7,779,266)x1,8p11.22(39,258,894-39,381,514)x1,
9q34.3(139,390,541-139,438,547)x2,10q11.22(46,938,469-47,691,285)x1,10q26.13(124,347,870-124,351,275)x3
,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)x3,16q21(60,292,273-65,919,653)
x2,17p13.1(7,572,822-7,590,998)x2,17q21.33(48,263,136-48,275,584)x2,21p11.2(10,743,033-10,838,151)x2
arr(1-22)x2,(XY)x1
(table continues)
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Table III: CGH+SNP results before and after exclusion of germline lesions based on ISCN (2013) (Continued)
Subject ID Before Germline Exclusion After Germline Exclusion
S11 arr Xp11.22p11.21(50,325,888-57,999,932)x2 hmz,Xq11.2q12(63,663,978-67,645,007)x2 
hmz,1p36.32(2,822,585-5,271,086)x2,1p36.23p36.22(8,180,442-10,490,014)x2,1p36.13(16,833,957-17,091,284)
x3,1q43(237,728,098-240,076,771)x2,2p23.3(25,457,245-25,537,174)x2,2p11.2(89,141,608-89,319,978)x4,2
p11.2p11.1(89,342,480-92,035,200)x2,4p14(38,960,195-40,869,416)x2,7p12.1p11.2(51,670,577-55,357,325)
x2,8p22(15,952,011-16,021,744)x4,8q24.22(132,311,479-136,004,054)x2 hmz,9q34.3(139,390,541-139,418,283)x2,1
2q24.11q24.13(110,641,965-112,939,841)x2,14q11.2(19,376,762-20,421,677)x3,14q32.33(106,331,956-106,526,266)
x3,14q32.33(106,416,316-106,449,894)x3,14q32.33(106,469,365-106,497,204)x3,14q32.33(106,636,701-106,943,374)
x4,16q21(59,804,745-65,569,348)x2,17q21.33(48,261,448-48,276,293)x2,22q11.1(16,054,691-16,434,984)x3,2
2q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S12 arr Xp22.33(145,768-2,656,392)x1,Yp11.32p11.2(95,768-10,084,438)x1,2p23.3(25,457,245-25,536,922)x2,2p1
2p11.2(82,457,898-85,503,996)x2 hmz,2p11.2(89,185,302-89,319,978)x3,5p13.1p11(41,623,186-46,105,865)x2 
hmz,5q11.1q11.2(49,623,539-52,549,193)x2 hmz,7p12.2(50,344,456-50,344,689)x6,8p23.1(7,239,491-7,779,266)
x2,8p11.22(39,258,894-39,381,514)x1,9p11.2(44,318,661-47,212,321)x2,9q34.3(139,390,541-139,440,753)x2,1
0q11.22(46,938,469-47,691,285)x2,11q22.3(103,709,577-107,118,116)x2 hmz,14q11.2(19,728,641-20,421,677)x3,
14q32.33(105,955,083-106,243,254)x2,14q32.33(106,331,956-107,211,941)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,636,701-106,803,307)x3,15q11.1q13.2(20,012,645-30,870,463)x2,16p12.2(22,563,832-22,739,647)
x2,16p11.2p11.1(33,798,324-35,257,727)x2,16q21(60,292,273-65,569,348)x2,17q21.33(48,262,645-48,273,578)x2,1
7q25.3(79,047,509-79,979,742)x2,18p11.21(14,285,197-15,362,169)x2,20q11.21(30,946,056-31,021,801)x2,21p11.
2p11.1(9,412,632-11,151,933)x2,22q11.21(18,661,724-18,830,629)x1
arr(1-22)x2,(XY)x1
S13 arr Yq11.1q11.21(13,250,971-13,637,320)x1,1p21.3(96,737,383-99,657,787)x2 hmz,1q1
2q21.1(142,552,678-143,467,738)x3,2p23.3(25,462,140-25,537,174)x2,2p11.2(89,185,302-89,319,978)
x3,2q21.2(132,649,661-132,917,197)x3,4p16.3(12,440-71,611)x3,4p16.3(1,785,020-1,807,211)
x2,4p11(49,215,538-49,535,522)x3,4q35.2(190,465,986-190,678,708)x2,5q32(149,441,077-149,513,209)
x2,7p22.2(2,949,734-2,985,479)x2,7q11.23(73,456,979-73,480,302)x2,8p23.1(7,239,491-7,779,266)x1,
8q24.3(145,736,666-145,742,554)x3,9p13.1p12(40,297,447-41,241,382)x2,9p12p11.2(43,464,701-43,910,995)x2
,9q34.3(139,390,541-139,438,547)x3,10q11.22(46,938,469-47,691,285)x2,10q26.13(124,325,486-124,358,140)
x3,11q13.4(71,752,020-74,336,144)x2,11q22.3(108,093,454-108,094,056)x2,12p11.21(31,108,073-32,538,445)
x2,13q11(19,024,748-19,420,378)x3,14q11.2(19,159,168-20,143,830)x2,14q21.3q22.1(49,789,136-51,189,256)x2,14q
32.32q32.33(103,430,083-104,837,294)x2,14q32.33(106,110,414-106,239,525)x3,14q32.33(106,331,956-107,216,227)
x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,535,379-106,566,896)x1,14q32.33(106,636,701-106,803,307)
x3,15q11.1q11.2(20,149,475-22,698,581)x3,15q14(34,695,166-34,841,446)x1,16p13.3(2,088,438-2,138,687)
x2,16p11.2p11.1(31,986,127-34,777,244)x2,17p13.1(8,045,240-8,055,686)x2,17q11.2(29,557,005-29,562,744)
x2,17q25.3(79,929,994-79,975,493)x2,18p11.21(14,196,900-15,325,187)x3,19p13.3(1,613,331-1,619,870)
x2,19p13.3(4,361,166-4,364,108)x3,19q13.2(42,387,965-42,799,912)x3,19q13.2(42,415,076-42,780,391)x1,21p11.
2p11.1(9,412,632-11,176,309)x3,21q11.2q22.2(14,458,104-41,390,185)x3,21q11.2q21.1(15,336,412-18,485,980)x3,
21q21.1(20,967,012-21,288,932)x3,21q21.2q21.3(24,101,544-27,229,275)x3,21q21.3q22.12(30,255,817-37,659,571)
x3,21q22.13q22.2(38,344,540-41,347,582)x3,21q22.2q22.3(41,429,018-48,090,317)x1,21q22.
2q22.3(41,464,836-47,376,507)x2 hmz,21q22.3(44,518,722-46,115,982)x1,21q22.3(47,737,355-47,863,878)x1,2
2q11.21(18,551,722-18,830,629)x1,22q12.1(28,193,727-28,197,407)x3
arr(1-22)x2,(XY)x1
S14 arr Xp22.33(63,303-2,656,392)x1,Yp11.32p11.31(13,303-2,606,392)x1,Yq11.1q11.21(13,250,971-13,872,561)
x1,1p35.1(32,739,700-32,741,965)x3,1q12q21.1(142,552,678-145,311,102)x2,2p23.3(25,461,919-25,537,174)
x3,2p11.2(89,185,302-89,319,978)x3,4p16.3p11(12,440-49,535,522)x3,4q11q35.2(52,672,433-190,874,516)
x3,4q31.3(151,211,578-155,355,055)x3,5q32(149,433,880-149,514,558)x3,6q25.3(156,504,597-157,095,208)
x1,7p22.2(2,949,734-2,985,479)x2,7p12.2(50,444,439-50,459,342)x3,7q11.23(73,432,241-73,483,107)
x3,8p23.1(7,239,491-7,779,266)x1,8q24.3(145,736,666-145,741,874)x3,9p11.2(44,418,648-47,212,321)x3,
9q34.3(139,390,541-139,440,753)x3,10q26.13(124,325,486-124,381,604)x3,11p12(36,476,372-41,019,615)x2 hm
z,11q13.4(71,715,018-71,725,437)x3,11q22.3(108,093,454-108,094,386)x3,14q32.2(98,129,865-99,360,391)x1,1
4q32.33(106,113,380-106,239,525)x3,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,636,701-106,803,307)x3,16p13.3(2,100,439-2,138,687)x3,16p13.11(15,476,833-16,311,070)x2
,16p12.2(22,563,832-22,780,312)x3,16p11.2p11.1(31,986,127-35,257,727)x2,17p13.1(7,573,861-8,055,686)x2
,17q12q21.2(37,811,339-38,513,367)x2,17q21.33(48,256,223-48,278,913)x3,17q25.3(79,941,446-79,975,300)
x3,19p13.3(1,217,820-1,830,585)x2,19p13.3(4,361,166-4,364,108)x3,19q13.2(42,386,884-42,799,912)x3,1
9q13.32(45,855,524-45,873,671)x3,20q11.21(30,921,700-31,019,558)x2,22q11.21(18,551,722-18,830,629)x1,2
2q11.21(19,707,321-19,716,812)x3,22q11.22q11.23(23,244,577-23,632,565)x3,22q12.1(28,193,391-28,197,407)x3,2
2q12.3(36,680,285-36,722,637)x3,22q13.1(40,807,285-40,832,480)x3
arr 4p16.3p11(12,440-49,535,522)x3,4q1
1q35.2(52,672,433-190,874,516)x3
S15 arr 2p23.3(25,459,981-25,537,174)x2,2p11.2(89,185,302-89,319,978)x3,5p15.33(459,407-900,380)x3,
7q11.21(64,701,173-65,092,262)x3,8p23.1(7,239,491-7,779,266)x1,8p11.22(39,258,894-39,381,514)x1,
9q34.3(139,390,541-139,418,283)x2,10q11.22(46,938,469-47,691,285)x1,14q32.33(106,331,956-107,216,227)x3,1
4q32.33(106,469,365-106,513,022)x3,14q32.33(106,803,248-107,216,227)x3,15q11.2(22,297,051-22,586,951)x1,1
7q21.33(48,261,783-48,273,578)x2,21p11.2(10,710,871-10,838,151)x3,22q11.21(18,661,724-18,830,629)x1
arr(1-22)x2,(XY)x1
S16 arr Xp22.33(63,303-2,656,392)x1,Yp11.32p11.31(13,303-2,606,392)x1,1p36.32(3,258,786-4,533,747)
x2,1p34.1(45,797,437-45,806,268)x2,1q23.1(156,833,328-156,846,353)x2,2p23.3(25,458,440-25,537,174)
x3,2p23.2(29,177,012-29,629,281)x2,2p12p11.2(77,525,189-84,089,013)x2,2p11.2(89,185,302-89,319,978)
x2,2p11.2(89,342,480-90,248,715)x1,2q13(110,862,477-110,964,737)x2,2q22.1(139,543,888-141,930,930)
x2,3p21.31(48,712,000-48,727,183)x2,3p14.2p14.1(63,611,060-66,842,564)x2 hmz,4p16.3(12,440-56,887)
x3,4p16.3(1,801,459-1,810,070)x2,4q12q13.2(58,415,025-67,472,979)x2,5q32(149,433,311-149,516,292)x3,
6p12.3p12.2(48,440,605-52,055,434)x2,6q16.1(95,456,808-95,662,059)x1,7p22.2(2,949,734-2,987,287)x2,7
p12.3p11.2(48,356,663-55,273,357)x2,7q11.23(73,442,449-73,481,111)x2,7q11.23(75,169,284-75,190,709)
x2,8p23.2(3,047,146-5,302,666)x2,8p23.1(7,220,322-7,779,266)x1,8p11.23(38,270,907-38,287,231)x2,
8p11.22(39,258,894-39,381,514)x0,8q24.3(145,737,350-145,742,554)x2,9p13.2p11.2(36,839,052-47,212,321)x2,
9q12q21.11(65,632,517-70,901,873)x2,9q34.3(139,390,541-139,438,547)x3,10q11.21(43,600,689-43,620,437)x2,
10q11.22(46,938,469-47,672,307)x1,10q23.1(82,668,806-85,284,029)x2,10q24.32(104,154,391-104,162,707)x3,1
0q26.13(124,325,486-124,377,004)x3,11q13.4(71,715,018-71,747,017)x2,11q22.3(108,158,472-108,160,532)x1,1
2q13.13(53,554,538-53,566,453)x2,12q24.31(121,426,649-121,451,456)x2,14q32.33(105,052,722-106,269,317)x2
,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,561,182)x3,15q11.2(22,297,051-22,648,497)
x1,15q26.1(91,428,387-91,447,053)x2,16p13.3(2,105,434-2,138,073)x3,16p13.13(10,989,225-11,017,773)x2
,16p13.11(15,808,279-16,311,070)x2,16p13.11(16,364,101-16,772,356)x1,16p12.3(18,608,635-18,779,974)
x1,16p12.2(22,563,832-22,758,443)x2,16p11.2(32,207,321-32,624,637)x2,16p11.2(33,304,631-33,773,163)
x1,16q24.3(89,805,670-90,025,225)x2,17p13.1(7,572,822-8,055,686)x3,17q21.33(48,263,136-48,275,584)x3
,17q25.3(79,941,446-79,975,300)x2,19p13.3(1,219,360-1,656,386)x2,19p13.11(17,935,889-18,896,635)x2,1
9q13.2(40,737,857-40,748,500)x2,19q13.2(42,386,884-42,799,051)x2,19q13.32(45,837,564-45,873,671)x2,1
9q13.33(48,228,949-48,260,496)x2,20q11.21(30,901,343-31,021,801)x2,21q22.3(47,731,338-47,930,431)x2,2
2q11.21(19,168,291-19,851,138)x2,22q11.23(23,574,219-23,657,804)x2,22q12.3(36,680,285-36,716,968)x2
arr(1-22)x2,(XY)x1
(table continues)
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Table III: CGH+SNP results before and after exclusion of germline lesions based on ISCN (2013) (Continued)
Subject ID Before Germline Exclusion After Germline Exclusion
S17 arr Xp22.33(63,303-2,656,392)x1,Yp11.32p11.31(13,303-2,606,392)x1,1p31.1p21.2(70,314,219-102,056,219)x1,1p31.
1p21.1(70,422,901-102,223,286)x2 hmz,1p21.1p13.3(103,253,503-108,146,890)x2,1q25.3(183,195,938-183,209,457)
x2,2p23.3(25,461,919-25,536,922)x2,2p16.3(49,373,865-51,986,860)x2,2p11.2(89,185,302-89,319,978)x2
,2q22.1(139,586,429-141,819,727)x2,3p26.3(1,601,269-2,562,334)x2,4q12q13.2(57,723,271-67,472,979)
x2,4q24(106,067,203-106,068,168)x5,5q11.1q11.2(50,206,819-52,354,843)x2,5q13.2(68,849,594-70,636,824)
x1,5q32(149,433,311-149,514,558)x2,6p12.3(48,440,605-51,649,477)x2,7p12.3p11.2(48,315,444-55,273,357)
x3,7p12.2(50,344,456-50,344,689)x3,7q11.23(73,432,241-73,481,035)x2,8p23.1(7,220,322-7,779,266)
x1,9p13.2(36,838,638-37,033,992)x2,9q34.3(139,390,541-139,438,547)x2,10q11.22(46,938,469-47,672,307)x1,1
0q24.32(104,154,391-104,162,707)x2,10q26.13(123,883,701-124,987,771)x2,11q21(95,889,755-95,961,627)x2,12q2
4.11q24.13(110,609,255-112,519,684)x2,14q32.33(104,708,728-106,251,883)x2,14q32.33(106,331,956-107,216,227)
x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,636,701-106,803,307)x3,15q11.2(22,297,051-22,648,497)
x1,15q14(34,695,166-34,841,446)x2,16p13.3(2,088,438-2,138,687)x2,17p13.1(7,573,861-10,021,521)x2,1
7q21.33(48,263,136-48,275,584)x3,20q11.21(30,956,726-31,021,801)x2
arr 1p31.1p21.2(70,314,219-102,056,219)
x1
S18 arr Xp22.33(63,303-2,656,392)x1,Xp11.23(48,525,493-48,891,441)x1,Yp11.32p11.31(13,303-2,606,392)x1
,1p36.13(18,957,565-19,072,669)x2,1p36.13(19,969,814-19,984,527)x2,1p35.1(32,739,700-32,751,421)x2
,1q21.2(148,609,572-149,224,043)x1,1q23.1(156,833,328-156,846,353)x2,2p23.3(25,457,245-25,537,174)
x3,2p23.2(29,402,944-29,606,628)x2,2p11.2(89,185,302-89,319,978)x3,2p11.2(89,342,480-90,248,715)
x1,2q13(113,860,604-114,046,312)x2,4p16.3(1,801,459-1,809,469)x2,4q24(106,067,203-106,068,228)
x4,5q32(149,433,880-149,516,292)x2,7p12.2(50,332,185-50,459,474)x3,7p12.2(50,427,655-50,436,941)x1
,7q11.23(73,442,449-73,481,111)x2,7q11.23(75,165,519-75,228,544)x2,7q36.1(148,504,728-148,515,262)
x2,8p23.1(7,239,491-7,779,266)x1,8p11.22(39,258,894-39,381,514)x0,8q24.3(145,737,350-145,741,403)
x2,9p13.2(36,839,459-37,034,645)x2,9q34.3(139,390,541-139,438,547)x3,10q11.21(43,571,616-43,623,741)x2,1
0q11.22(46,938,469-47,691,285)x1,10q24.32(104,154,391-104,162,707)x3,10q26.13(124,291,833-124,396,755)x2,
11q13.4(71,715,797-71,747,017)x2,11q22.3(108,093,454-108,094,351)x2,12q24.31(121,426,649-121,439,580)x2,1
4q32.33(106,037,979-106,263,147)x2,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)x3
,14q32.33(106,531,557-106,561,182)x3,14q32.33(106,636,701-106,803,307)x3,14q32.33(106,906,901-107,216,227)
x3,15q26.1(91,428,387-91,439,009)x2,16p13.3(2,105,434-2,138,687)x2,16q13q21(56,973,009-58,789,627)
x2,16q24.3(89,388,113-89,799,712)x2,17p13.1(7,572,822-8,055,686)x2,17q12(36,861,875-36,880,910)
x2,17q12(37,863,329-37,883,968)x2,17q21.33(48,263,136-48,275,584)x3,19p13.3(1,610,115-1,656,386)
x2,19p13.3(1,830,527-4,349,889)x2,19p13.11(17,935,889-17,958,844)x2,19p13.11(18,848,025-18,892,515)x2,
19q13.2(42,350,228-42,799,051)x2,19q13.32(45,837,564-45,873,671)x2,20q11.21(30,946,056-31,021,678)x2,2
1q22.12(36,245,802-36,295,397)x1,22q11.1(16,153,099-16,417,067)x1,22q11.21(18,661,724-18,830,629)x2,2
2q11.21(19,707,321-19,721,668)x2,22q12.1(28,194,834-28,197,407)x2
arr(1-22)x2,(XY)x1
S19 arr 1q21.2(149,041,013-149,202,620)x1,2p11.2(89,185,302-89,319,978)x3,2q14.2(121,886,806-122,336,492)
x3,3p26.3(243,433-403,431)x2,8p23.1(7,239,491-7,779,266)x1,8p11.1(43,128,013-43,520,355)x2 hmz,8q11.
1q11.21(46,940,022-51,547,523)x2 hmz,9p13.1(39,092,761-40,719,201)x2,9p12p11.2(43,315,599-43,874,898)x1,1
0q11.22(46,938,469-47,691,285)x1,10q26.13(124,347,870-124,351,275)x4,12p13.31p12.1(9,924,796-22,235,083)
x1,14q11.2(19,255,744-20,421,677)x3,14q11.2(22,277,272-22,952,279)x2,14q32.33(106,331,956-107,216,227)x3,1
4q32.33(106,469,365-106,497,204)x3,14q32.33(106,469,365-106,561,182)x3,14q32.33(106,636,701-106,803,307)x1
0,14q32.33(106,850,403-107,211,941)x3,15q11.2(22,318,597-22,648,497)x1,17q21.31(44,485,771-44,762,618)x3,2
2q11.21(18,661,724-18,830,629)x1
arr 12p13.31p12.1(9,924,796-22,235,083)
x1
S20 arr Xq27.2q27.3(141,690,336-145,591,175)x2 hmz,2p11.2(89,141,608-89,319,978)x4,2p11.2(89,538,815-90,003,752)
x3,4q22.1q24(90,114,138-101,127,081)x2 hmz,6q15(89,272,006-91,954,911)x2 hmz,8p22(15,952,011-16,021,744)
x4,8p11.22(39,258,894-39,381,514)x10,9p13.1p12(40,654,070-43,429,530)x2,14q11.2(19,255,744-20,421,677)x3,1
4q32.33(106,331,956-106,552,084)x3,14q32.33(106,357,649-106,392,806)x3,14q32.33(106,469,365-106,513,022)x3,1
4q32.33(106,636,701-106,943,374)x4,15q11.1q11.2(20,399,030-22,698,581)x3,22q11.21(18,661,724-18,830,629)x1,2
2q11.22(23,056,562-23,244,636)x10
arr 4q22.1q24(90,114,138-101,127,081)
x2 hmz
S21 arr Xp22.33(63,303-1,945,721)x2,Xp11.23(48,525,493-48,658,937)x3,2p23.3(25,456,917-25,537,174)
x2,2p16.3(49,231,108-52,519,423)x2,2p11.2(89,141,608-89,319,978)x5,2p11.2p11.1(89,538,815-92,184,540)
x2,4q13.2(70,108,664-70,223,408)x1,4q28.3(138,123,923-138,261,712)x1,4q34.3q35.1(177,998,382-183,337,339)
x2,7p12.1p11.2(51,376,150-54,742,296)x2,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,8
q11.21q11.23(50,806,102-53,436,068)x2 hmz,8q24.3(145,532,050-145,897,770)x2,9p11.2(44,318,661-45,036,533)
x3,9q34.3(139,390,541-139,418,283)x2,11p12(38,035,794-42,125,623)x2,14q21.2q21.3(45,979,670-48,518,396)x2,
14q32.33(106,037,979-106,239,525)x3,14q32.33(106,331,956-106,561,182)x3,14q32.33(106,375,298-106,449,894)
x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,566,837-106,943,374)x3,15q14(34,695,166-34,841,446)
x1,16p11.2(32,015,694-34,363,720)x2,17p13.1(7,572,822-7,590,998)x2,17q21.33(48,263,136-48,275,584)x2,1
7q25.3(79,047,509-79,975,300)x2,22q11.21(19,707,321-19,716,812)x2,22q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S22 arr Xp22.33(63,303-2,656,392)x1,Yp11.32p11.31(13,303-2,606,392)x1,2p23.3(25,456,917-25,537,174)
x2,2p11.2(89,185,302-89,319,978)x3,6p22.1(29,675,515-30,098,664)x1,8p23.1(7,239,491-7,779,266)x1,
8p11.22(39,258,894-39,381,514)x1,9q34.3(139,390,541-139,438,547)x2,10q11.22(46,938,469-47,691,285)x1,1
4q32.33(106,113,380-106,239,525)x3,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)x3,1
4q32.33(106,636,701-106,803,307)x3,17q21.33(48,262,645-48,273,777)x2,22q11.21(18,661,724-18,830,629)x1
arr(1-22)x2,(XY)x1
S23 arr Xp22.33p11.1(2,695,374-58,246,917)x1,Xp11.23(48,013,124-48,896,732)x1,Xq11.1q28(61,934,507-155,102,406)
x1,Xq11.2(63,409,439-63,429,474)x1,Xq26.1(129,199,147-129,244,885)x1,1q43(237,728,098-240,076,771)
x2,2p23.3(25,457,245-25,537,174)x2,2p11.2(89,141,608-89,319,978)x4,2p11.2p11.1(89,538,815-92,184,540)x2,
2q32.1q32.2(188,471,271-191,169,948)x2 hmz,8p23.1(7,239,491-7,779,266)x1,8p22(15,952,011-16,021,744)x4,
8p11.22(39,258,894-39,381,514)x10,9p13.1p11.2(39,167,334-47,212,321)x2,9q13q21.11(66,151,746-71,046,091)
x2,9q34.3(139,390,541-139,418,283)x2,12q12(41,634,082-43,750,710)x1,14q11.2(19,376,762-20,421,677)x3,1
4q32.33(106,037,979-106,243,254)x2,14q32.33(106,331,956-106,552,084)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,566,837-107,124,579)x2,16p11.2(32,015,694-34,384,670)x2,17q21.33(48,261,783-48,275,584)x2,2
2q11.22(23,056,562-23,244,636)x10
arr Xp22.33p11.1(2,695,374-58,246,917)
x1,Xq11.1q28(61,934,507-155,102,406)x1
S24 arr 2p11.2(89,185,302-89,319,978)x4,4q12q13.1(58,728,642-64,671,240)x2 hmz,4q21.2
3q22.2(86,243,959-94,736,376)x2 hmz,4q23q25(100,500,130-108,394,042)x2 hmz,4q25(108,624,907-113,483,843)
x2 hmz,4q26(116,914,182-120,612,158)x2 hmz,4q28.1q28.2(124,165,289-129,503,678)x2 hmz,4q
31.21q31.3(144,333,710-152,861,685)x2 hmz,4q32.1q33(157,578,308-170,984,825)x2 hmz,4q34.
1q35.2(172,152,981-190,449,761)x2 hmz,8p23.1(7,239,491-7,779,266)x1,8p11.22(39,258,894-39,381,514)
x1,9p23(11,952,522-12,163,289)x1,9p13.1p11.2(38,459,475-47,212,321)x2,10q11.22(46,938,469-47,691,285)
x1,11p12(37,610,467-40,278,016)x2 hmz,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,561,182)
x3,16p11.2p11.1(32,550,921-35,257,727)x2,17q21.33(48,263,792-48,274,043)x2
arr 4q12q13.1(58,728,642-
64,671,240)x2 hmz,4q21.2
3q22.2(86,243,959-94,736,376)x2 hmz,4
q23q25(100,500,130-108,394,042)x2 hm
z,4q28.1q28.2(124,165,289-129,503,678)
x2 hmz,4q31.2
1q31.3(144,333,710-152,861,685)x2 hm
z,4q32.1q33(157,578,308-170,984,825)
x2 hmz,4q34.
1q35.2(172,152,981-190,449,761)x2 hmz
(table continues)
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Table III: CGH+SNP results before and after exclusion of germline lesions based on ISCN (2013) (Continued)
Subject ID Before Germline Exclusion After Germline Exclusion
S25 arr 2p23.3(25,456,917-25,537,174)x2,2p11.2(89,141,608-89,319,978)x4,7p14.1(38,295,198-38,378,991)
x1,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,9p21.3p11.2(20,574,205-47,212,321)x2,9q2
1.2q21.32(80,617,300-85,947,216)x2,11q23.3q25(119,172,038-134,934,196)x2,14q11.2(19,709,805-20,421,677)x3,
14q11.2(22,358,442-23,019,786)x1,14q32.33(106,331,956-106,552,084)x3,14q32.33(106,375,298-106,392,806)x3,1
4q32.33(106,416,316-106,465,578)x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,555,946-106,943,374)x2
,15q15.1(40,494,506-42,062,587)x2,16q21(62,851,908-65,712,545)x2 hmz,17q21.33(48,264,359-48,274,043)x2,17q2
2q24.1(57,263,393-63,919,311)x2 hmz,22q11.22(23,056,562-23,244,636)x10
arr 9q21.2q21.32(80,617,300-85,947,216)
x3
S26 arr 2p11.2(89,185,302-89,319,978)x4,7q21.12q21.13(87,148,265-90,826,257)x2 hmz,8p23.2(2,351,976-2,794,488)
x3,8p23.1(7,239,491-7,779,266)x1,8p11.22(39,258,894-39,381,514)x0,9q34.3(139,393,586-139,438,408)x2,1
0q11.22(46,938,469-47,691,285)x1,10q21.1(57,630,800-60,333,847)x2 hmz,10q26.13(124,347,870-124,351,275)
x4,10q26.3(135,252,867-135,386,958)x3,12q21.31q21.33(84,392,856-89,698,922)x2 hmz,14q1
2q22.2(29,504,400-55,455,087)x2 hmz,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)x3,1
4q32.33(106,636,701-106,803,307)x3,14q32.33(106,850,403-107,216,227)x3,16p11.2p11.1(32,015,694-35,257,727)x2,
18q21.2q21.31(48,917,970-54,128,364)x2 hmz,22q11.21(18,661,724-18,830,629)x1
arr 18q21.
2q21.31(48,917,970-54,128,364)x2 hmz
S27 arr Xp22.33(145,768-2,778,548)x2,2p23.3(25,456,917-25,537,174)x2,2p11.2(89,141,608-89,319,978)
x5,8p23.1(7,220,322-7,779,266)x3,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)
x10,9p23(10,273,068-13,331,466)x2 hmz,9q34.3(139,390,541-139,438,371)x2,11q22.3(108,127,062-108,173,473)x2,1
1q23.3(118,338,407-118,354,958)x4,14q21.2q22.1(45,046,941-51,153,409)x2 hmz,14q32.33(106,331,956-106,552,084)
x3,14q32.33(106,375,298-106,392,806)x3,14q32.33(106,416,316-106,449,894)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,555,946-106,943,374)x3,15q11.1q11.2(20,399,030-22,558,756)x3,17p13.1(7,572,822-7,590,998)x3,1
7q21.33(48,264,131-48,274,043)x2,22q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S28 arr Xp22.33(63,303-2,865,335)x2,Xq21.31(90,058,366-91,519,765)x1,1p36.32(2,335,096-4,901,389)x2
,1q21.2(149,041,013-149,202,620)x1,2p23.3(25,456,917-25,537,174)x2,2p12(78,658,294-78,833,712)
x1,2p11.2(89,141,608-89,319,978)x4,6p22.2p21.33(26,311,321-30,467,695)x2 hmz,7p14.1(38,295,198-38,369,498)
x1,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,10q23.31(89,644,976-91,626,668)x2,1
4q11.2(19,434,575-20,143,830)x2,14q11.2(22,358,442-23,019,786)x1,14q32.33(106,037,979-106,232,567)x3,1
4q32.33(106,331,956-106,552,084)x3,14q32.33(106,357,649-106,465,578)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,636,701-106,943,374)x4,15q11.2(22,318,597-22,586,951)x1,16p11.2(33,339,542-34,363,720)x2,1
7q21.33(48,261,783-48,275,584)x2,22q11.21(19,707,321-19,825,562)x2,22q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S29 arr Xp22.33(63,303-2,656,392)x1,Yp11.32p11.31(13,303-2,606,392)x1,2p23.3(25,456,917-25,537,174)
x2,2p11.2(89,185,302-89,319,978)x3,6p22.1(29,675,515-30,098,664)x1,8p23.1(7,239,491-7,779,266)x1,
8p11.22(39,258,894-39,381,514)x1,9q34.3(139,390,541-139,438,547)x2,10q11.22(46,938,469-47,691,285)x1,1
4q32.33(106,113,380-106,239,525)x3,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,513,022)x3,1
4q32.33(106,636,701-106,803,307)x3,17q21.33(48,262,645-48,273,777)x2,22q11.21(18,661,724-18,830,629)x1
arr(1-22)x2,(XY)x1
S30 arr Yq11.21q11.223(13,675,923-22,550,312)x1,Yq11.223(23,021,108-23,114,008)x1,1p36.33p36.22(746,608-9,349,080)
x2,2p23.3(26,692,246-26,801,287)x4,2p11.2(89,185,302-89,319,978)x4,2q21.1(130,907,973-131,144,665)x3,3p26.
3p11.1(68,644-90,489,421)x1,3p26.3p11.1(107,994-90,064,515)x2 hmz,3q11.1q29(93,538,467-197,840,323)x1,3q11.
2q29(93,989,454-197,802,470)x2 hmz,3q13.13q21.2(111,119,902-125,370,235)x1,3q22.1(129,739,996-130,003,876)x1,
5q14.3q35.3(85,701,372-180,696,806)x1,5q14.3q35.3(85,770,686-180,614,665)x2 hmz,5q32(149,427,775-149,545,238)
x1,7p22.3p12.1(65,558-53,303,719)x1,7p22.3p21.3(90,167-8,717,542)x1,7p22.3p21.3(891,338-8,865,997)x2 hmz,7p21.
3p21.1(10,306,955-16,652,639)x2 hmz,7p21.3p21.1(10,649,696-16,535,901)x1,7p14.3p12.3(33,883,154-47,103,211)x2 
hmz,7p14.3p12.3(34,145,878-47,097,701)x1,7p12.3p12.1(48,050,043-53,303,719)x1,7p12.2(50,444,542-50,459,342)x2,
7q21.11q36.3(85,631,245-159,030,335)x2 hmz,7q21.11q36.3(85,765,132-159,075,079)x1,8p23.1(7,239,491-7,779,266)
x1,8p11.22(39,258,894-39,381,514)x1,9p23(10,721,924-12,405,079)x1,9p23(12,424,341-13,234,954)
x3,9p22.3(15,870,462-16,343,955)x1,9p22.3p21.3(16,375,027-21,584,042)x3,9p22.3p22.2(16,401,595-17,869,257)x3
,9p21.3p21.2(22,801,570-26,833,141)x2 hmz,9p21.3p21.2(22,822,144-26,851,028)x1,9p21.2(26,886,731-27,718,516)
x3,9p21.1(28,606,661-28,932,450)x1,9p21.1(28,957,785-29,066,933)x4,9p21.1(29,085,216-29,544,123)
x1,9p21.1(29,879,482-31,923,974)x3,9p21.1(31,341,152-31,923,974)x3,9p13.3(33,957,741-34,203,001)x4,9p13.
3p13.1(34,556,560-40,719,201)x1,9p13.3p13.2(35,113,110-36,620,362)x1,9p13.1(38,403,205-40,322,594)x1,9p1
2p11.2(43,315,599-43,841,603)x1,10q11.22(46,938,469-47,691,285)x1,10q26.13(124,347,870-124,358,140)x3,11p1
5.5p15.4(205,172-4,609,561)x2,12p13.33(1,176,383-2,387,033)x3,12p13.33p13.31(1,176,383-8,291,515)x3,12p13.3
3p13.31(2,704,800-8,048,500)x4,12p13.2p12.1(10,832,372-21,312,063)x1,12p13.2p12.1(10,847,527-21,320,686)x2 hm
z,12p12.1(21,356,582-22,482,505)x3,12p12.1p11.23(25,889,551-26,713,340)x1,13q11q12.3(19,149,060-30,342,672)
x3,13q11q12.13(19,227,564-26,035,359)x3,13q12.13q12.3(26,379,864-30,322,265)x3,13q12.
3q31.2(29,720,371-88,051,460)x2 hmz,13q12.3q31.1(30,404,904-87,111,281)x1,14q11.2(19,663,407-20,421,677)x1
,14q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,561,182)x3,14q32.33(106,803,248-107,211,941)
x3,16p13.11(15,496,393-16,289,746)x3,19p13.3(715,326-1,207,182)x3,22q11.21(18,661,724-18,830,629)x1,2
2q11.21(21,536,794-21,704,972)x1,22q11.23(25,644,713-25,892,401)x3
arr Yq11.2
1q11.223(13,675,923-22,550,312)x1,3p
26.3p11.1(68,644-90,489,421)x1,3q11.
1q29(93,538,467-197,840,323)x1,3q13
.13q21.2(111,119,902-125,370,235)x1,
5q14.3q35.3(85,701,372-180,696,806)
x1,7p22.3p12.1(65,558-53,303,719)
x1,7p22.3p21.3(90,167-8,717,542)x1,7p2
1.3p21.1(10,649,696-16,535,901)x1,7p14
.3p12.3(34,145,878-47,097,701)x1,7p12.
3p12.1(48,050,043-53,303,719)x1,7q21.1
1q36.3(85,765,132-159,075,079)x1,9p22
.3p21.3(16,375,027-21,584,042)x3,9p13.
3p13.1(34,556,560-40,719,201)x1,12p13
.33p13.31(1,176,383-8,291,515)x3,12p1
3.33p13.31(2,704,800-8,048,500)x4,13q
11q12.3(19,149,060-30,342,672)x3,13q1
1q12.13(19,227,564-26,035,359)x3,13q12
.3q31.1(30,404,904-87,111,281)x1
S31 arr Xp22.33(63,303-2,865,335)x2,2p23.3(25,457,245-25,537,174)x3,2p11.2(89,141,608-89,319,978)
x3,4p16.3(23,036-56,887)x3,4q24(106,067,203-106,068,168)x3,6q21(110,294,224-113,665,595)x2 hmz,
7p12.2(50,344,227-50,469,882)x3,7q11.23(73,449,704-73,481,035)x3,7q22.1q36.3(100,780,826-158,923,949)x1,7
q22.1q36.3(100,985,743-159,030,335)x2 hmz,7q33(137,560,258-137,593,146)x1,7q36.1(148,504,728-148,514,004)
x1,8p22(15,952,011-16,021,744)x4,9p13.2(36,839,459-37,034,645)x3,9p13.1p11.2(38,459,475-47,212,321)x2,
9q34.3(139,390,098-139,438,547)x3,10q26.3(135,242,075-135,386,958)x3,11p15.5p11.12(192,358-51,538,651)x3,
11q11q25(54,909,688-134,934,196)x3,11q23.3(118,342,216-118,353,292)x3,14q11.2(19,794,577-20,338,802)x3,1
4q32.33(106,037,979-106,269,317)x3,14q32.33(106,331,956-106,943,374)x3,14q32.33(106,469,365-106,513,022)
x3,15q25.3(86,809,339-86,980,779)x3,17p13.3p13.1(44,684-7,572,867)x1,17p13.3p13.1(72,083-7,940,754)x2 
hmz,17p13.3(1,959,507-1,961,561)x3,17p12p11.2(13,230,329-20,927,835)x2 hmz,17p12p11.2(13,236,413-22,128,401)
x1,17q11.1(25,458,873-25,569,094)x2 hmz,17q21.33(48,263,136-48,275,584)x3,19q13.41(53,052,678-53,433,028)x3,2
0q11.21(30,946,056-31,021,801)x2,22q11.22(23,056,562-23,244,636)x10
arr 7q22.
1q36.3(100,780,826-158,923,949)x1,11
p15.5p11.12(192,358-51,538,651)x3,11
q11q25(54,909,688-134,934,196)x3,17
p13.3p13.1(44,684-7,572,867)x1,17p1
2p11.2(13,236,413-22,128,401)x1
S32 arr Xq28(154,830,427-154,929,279)x3,2p11.2(89,141,608-89,319,978)x3,2p11.2p11.1(89,538,815-92,273,822)
x2,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,9p13.1p11.2(39,167,334-47,212,321)x2,
14q11.2(19,376,762-20,143,830)x3,14q11.2(22,358,442-23,019,786)x2,14q32.33(106,331,956-106,943,374)x3,1
4q32.33(106,469,365-106,513,022)x3,14q32.33(106,555,946-106,712,967)x3,15q11.1q11.2(20,399,030-22,698,581)x3,
22q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S33 arr 2p25.3(10,702-664,362)x2,2p23.3(25,459,981-25,537,174)x2,2p11.2(89,141,608-89,319,978)x5
,2p11.2p11.1(89,402,898-92,184,540)x2,4p16.3(12,440-56,887)x3,4p14(38,999,534-40,815,250)x2,
6q16.3(103,488,284-103,652,304)x1,8p22(15,952,011-16,021,744)x5,8p11.22(39,258,894-39,381,514)
x10,9p13.1(38,694,064-38,710,922)x2 hmz,9p13.1p11.2(39,115,086-46,361,897)x2,9q21.1
1q31.1(71,046,033-103,362,618)x1,9q21.11q31.1(71,046,583-103,571,020)x2 hmz,9q34.3(139,390,541-139,438,408)
x2,10q26.13(124,347,870-124,351,275)x1,14q11.2(19,376,762-20,421,677)x3,14q32.33(105,955,083-106,243,254)x2,1
4q32.33(106,331,956-106,552,084)x3,14q32.33(106,357,649-106,392,806)x3,14q32.33(106,416,316-106,449,894)x3,1
4q32.33(106,469,365-106,513,022)x3,14q32.33(106,636,701-106,943,374)x5,14q32.33(107,230,639-107,287,505)x3,18
q12.1q12.2(30,069,445-33,901,772)x2 hmz,22q11.22(23,056,562-23,244,636)x10
arr 9q21.1
1q31.1(71,046,033-103,362,618)x1
(table continues)
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Table III: CGH+SNP results before and after exclusion of germline lesions based on ISCN (2013) (Continued)
Subject ID Before Germline Exclusion After Germline Exclusion
S34 arr ,1q12q21.1(142,552,678-144,931,798)x2,2p23.3(25,472,637-25,498,457)x2,2p11.2(89,185,302-89,301,214)
x2,4p16.3(1,757,061-1,807,316)x2,4q13.1q13.2(61,127,613-70,298,721)x2 hmz,5q35.1(170,735,089-170,741,580)
x2,7p12.2(50,344,456-50,344,689)x4,8p23.1(7,220,322-7,779,266)x1,9p13.1p11.2(39,008,321-47,212,321)x2,9q
12q21.11(65,632,517-70,403,378)x2,9q34.3(139,390,541-139,490,407)x2,10q11.22(46,938,469-47,691,285)x2,1
0q26.13(124,347,870-124,351,275)x1,14q11.2(21,575,069-23,731,373)x2,14q32.33(106,331,956-107,216,227)x3,1
4q32.33(106,469,365-106,561,182)x3,14q32.33(106,636,701-106,803,307)x3,14q32.33(107,001,431-107,203,073)
x3,15q11.2(22,318,597-22,586,951)x1,16p11.2(33,304,631-33,773,163)x1,17q11.2(28,670,800-29,880,441)
x1,19p13.3(1,191,934-1,232,206)x2,19q13.2q13.31(43,261,778-43,783,380)x2,21p11.2p11.1(9,647,088-11,151,933)x2,
22q11.21(18,661,724-18,830,629)x1,22q12.1(28,193,727-28,196,474)x2
arr 4q13.1q13.2(61,127,613-70,298,721)
x2 hmz
S35 arr 1p36.13(16,833,957-17,051,239)x2,1p36.12(20,909,782-21,066,243)x3,2p23.3(25,457,245-25,537,174)
x2,2p11.2(89,185,302-89,319,978)x3,4q24(106,067,148-106,068,168)x4,5q13.2(68,849,594-70,636,824)
x1,7p12.2(50,344,456-50,344,689)x5,8p23.1(7,239,491-7,779,266)x1,9q34.3(139,390,541-139,418,283)x2,1
0q11.22(46,938,469-47,691,285)x1,10q22.2(76,788,224-76,790,091)x1,10q26.13(124,347,870-124,351,275)x5,1
4q32.33(106,331,956-107,216,227)x3,14q32.33(106,469,365-106,561,182)x3,15q11.1q11.2(20,481,702-21,941,153)x2,
15q11.2(22,297,051-22,669,111)x1,17q21.33(48,264,359-48,275,584)x2
arr(1-22)x2,(XY)x1
S36 arr 1q21.1(144,942,423-145,311,102)x3,2p11.2(89,141,608-89,319,978)x6,2q21.1q21.2(130,711,448-133,076,697)x2
,5q14.3q34(83,516,470-162,772,648)x2 hmz,5q14.3q34(83,525,460-162,507,695)x1,7p12.2(50,344,456-50,344,689)
x6,8p22(15,952,011-16,021,744)x6,8p11.22(39,258,894-39,381,514)x10,9p13.1p11.2(39,254,329-47,212,321)x2,1
4q11.2(19,376,762-20,421,677)x6,14q32.33(106,331,956-106,561,182)x3,14q32.33(106,469,365-106,513,022)x3,15q11
.1q11.2(20,399,030-22,698,581)x3,22q11.1(16,054,691-16,434,984)x3,22q11.22(23,056,562-23,244,636)x10
arr 5q14.3q34(83,525,460-162,507,695)x1
S37 arr 1p36.13(16,833,957-17,241,809)x3,1q21.2(149,041,013-149,202,620)x0,1q21.2(149,223,984-149,775,936)
x1,2p23.3(25,458,440-25,537,174)x2,2p21(42,430,345-45,770,687)x2 hmz,2p11.2(89,141,608-89,319,978)
x4,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,9p11.2(44,224,278-47,212,321)x2,
9q34.3(139,390,541-139,440,753)x2,14q11.2(19,376,762-20,421,677)x3,14q32.33(105,955,083-106,243,254)x2,1
4q32.33(106,331,956-106,552,084)x3,14q32.33(106,367,922-106,392,806)x3,14q32.33(106,416,316-106,465,578)
x3,14q32.33(106,469,365-106,513,022)x3,14q32.33(106,555,946-106,943,374)x3,16p13.3(2,105,434-2,138,687)x2,1
7q21.33(48,263,136-48,278,913)x2,22q11.1(16,054,691-16,197,064)x3,22q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S38 arr 1q21.1(144,930,656-145,079,845)x2,2p11.2(89,141,608-89,319,978)x4,5q22.1q22.3(111,447,639-114,710,474)
x2 hmz,6p22.2p22.1(25,739,644-29,503,782)x2 hmz,6p11.2(57,205,883-58,055,076)x3,8p22(15,952,011-16,021,744)
x4,8p11.22(39,258,894-39,381,514)x10,9p12p11.2(43,540,034-47,212,321)x2,14q11.2(19,255,744-20,290,684)x3,1
4q32.33(106,331,956-106,552,084)x3,14q32.33(106,354,395-106,392,806)x3,14q32.33(106,469,365-106,513,022)x3,
14q32.33(106,636,701-106,943,374)x4,15q11.1q11.2(20,399,030-22,698,581)x3,16p11.2(32,207,321-33,798,368)x2,2
2q11.22(23,056,562-23,244,636)x10
arr(1-22,X)x2
S39 arr Xp22.33p11.1(2,695,374-58,543,823)x1,Xp22.2p21.3(10,715,887-25,472,209)x1,Xp11.23(48,665,599-48,880,703)
x1,Xq11.1q28(61,781,601-155,102,406)x1,Xq24(118,767,374-118,832,973)x1,Xq26.1(129,199,147-129,244,885)
x1,2p23.3(25,456,917-25,537,174)x3,2p23.2(29,419,621-29,606,628)x2,2p16.3p16.2(49,570,941-53,212,136)
x2,2p11.2(89,141,608-89,319,978)x4,2q22.1(138,227,855-141,735,908)x2,2q32.3q33.1(196,064,399-199,776,769)
x2 hmz,4q24(106,066,996-106,180,973)x2,5q23.1(120,179,961-120,274,616)x1,6p25.3(283,968-381,382)x1
,7p22.1p21.3(6,916,324-7,335,136)x3,7q11.23(73,449,704-73,481,111)x2,7q21.11(78,781,210-84,891,396)
x2,8p22(15,952,011-16,032,825)x4,8p11.22(39,258,894-39,381,514)x10,8q24.3(145,737,350-145,741,403)
x2,9p13.2(36,839,459-37,034,645)x2,9p13.1p11.2(39,008,321-47,212,321)x2,9q34.3(139,390,541-139,438,547)x3
,10p12.2(24,270,288-24,580,655)x1,14q11.2(19,255,744-20,143,830)x3,14q32.33(106,037,979-106,239,525)x3,1
4q32.33(106,331,956-106,544,481)x3,14q32.33(106,354,395-106,392,806)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,636,701-106,943,374)x2,16p11.2(32,207,321-33,773,163)x1,17p13.1(7,572,822-7,590,998)
x3,17q12(36,859,669-36,884,594)x2,17q21.33(48,263,136-48,275,584)x3,19p13.3(1,206,486-1,663,934)x2,1
9p13.11(17,935,889-17,966,794)x2,19q13.2q13.32(42,350,228-45,873,671)x2,20q11.21(30,956,726-31,021,801)x2
,20q13.32(57,414,967-57,953,455)x2,22q11.21(19,707,321-19,716,812)x3,22q11.22(23,056,562-23,244,636)x3,2
2q11.22(23,087,094-23,144,851)x3,22q11.22(23,152,416-23,201,852)x3,22q12.3(36,680,285-36,707,231)x2
arr Xp22.33p11.1(2,695,374-58,543,823)
x1,Xp22.2p21.3(10,715,887-25,472,209)
x1,Xq11.1q28(61,781,601-155,102,406)x1
S40 arr Xp22.33(63,303-2,656,392)x3,Xp11.23(48,542,216-48,547,818)x3,1p35.1(32,739,700-32,751,421)
x2,1p34.1(45,797,437-45,806,268)x2,1q22(155,154,933-155,212,375)x2,1q23.1(156,833,328-156,846,353)
x3,1q43(237,668,915-240,419,384)x2,2p23.3(25,456,917-25,537,174)x3,2p23.2(29,416,368-29,551,250)
x2,2p11.2(89,141,608-89,319,978)x4,2p11.2(89,342,480-90,248,715)x1,2q14.3(127,807,997-127,828,379)
x2,3p21.31(48,712,000-48,723,181)x2,3q29(194,826,801-195,789,500)x2,3q29(196,730,908-196,755,703)
x3,4p16.3(12,440-45,941)x3,4p16.3(1,802,707-1,809,469)x2,4p14p13(38,830,948-41,269,183)
x2,4q24(106,067,203-106,068,228)x3,5q32(149,433,880-149,516,292)x2,7p12.2p11.2(50,305,021-55,273,357)
x3,7p12.2(50,427,655-50,436,941)x1,7q11.23(73,449,704-73,481,111)x3,7q11.23(75,176,243-75,189,138)
x2,8p22(15,952,011-16,043,322)x4,8p11.22(39,258,894-39,381,514)x10,8q24.3(145,737,350-145,743,935)
x2,9p13.3(35,074,930-35,088,472)x2,9p13.2(36,839,459-37,034,645)x3,9q22.32(98,201,651-98,513,438)x2,
9q34.3(139,390,541-139,438,547)x3,10q23.1(82,691,740-85,600,474)x2,10q24.32(104,154,391-104,161,803)x3
,11q13.3(70,253,461-70,280,132)x2,11q13.4(71,715,018-71,729,992)x3,11q22.3(108,093,454-108,094,351)x2,1
2q13.3(57,853,745-57,864,423)x2,12q24.31(121,426,649-121,438,978)x2,14q11.2(19,794,577-20,421,677)x3,1
4q32.33(106,037,979-106,239,525)x3,14q32.33(106,331,956-106,555,991)x3,14q32.33(106,469,365-106,513,022)
x3,14q32.33(106,561,123-106,943,374)x3,15q11.1q12(20,012,645-26,332,772)x2,15q26.1(91,428,387-91,437,286)
x2,16p13.3(2,105,434-2,138,687)x3,16p13.13(10,989,225-11,017,773)x2,16p13.11(15,802,738-16,225,792)
x2,16p11.2(32,015,694-34,427,859)x2,16q21(60,292,273-65,919,653)x2,16q24.3(89,322,147-89,357,532)x2
,16q24.3(89,811,420-90,030,199)x2,17p13.1(7,572,822-7,590,998)x3,17q12(36,859,669-36,884,187)x2,17
q12q21.2(37,850,874-38,513,367)x2,17q21.33(48,263,136-48,275,584)x3,17q25.3(79,832,664-79,975,300)
x2,18q21.2(50,181,426-51,053,152)x2,19p13.3(1,219,360-1,653,000)x3,19p13.3(4,360,346-4,366,948)x2,1
9p13.11(17,935,889-17,958,844)x3,19q13.2q13.32(42,386,884-45,873,671)x2,19q13.33(48,228,949-48,260,496)x2
,20q11.21(30,946,056-31,021,801)x2,20q13.32(57,407,840-57,495,925)x2,22q11.1q11.21(17,593,629-18,889,098)
x2,22q11.21(19,707,321-19,721,668)x3,22q11.22(23,056,562-23,244,636)x3,22q11.22(23,087,094-23,144,851)
x3,22q11.22(23,152,416-23,201,852)x3,22q12.1(28,192,866-28,197,407)x2,22q12.3(36,680,285-36,707,231)x2,2
2q13.1(40,802,894-40,820,240)x2
arr(1-22,X)x2
S41 arr Xp22.33p11.1(2,695,374-58,543,823)x1,Xp11.23(48,074,226-48,896,732)x1,Xq11.1q28(61,934,507-155,102,406)
x1,2p23.3(25,456,917-25,537,174)x2,2p11.2(89,141,608-89,319,978)x4,7q11.23(76,095,829-76,593,996)
x1,8p22(15,952,011-16,021,744)x4,8p11.22(39,258,894-39,381,514)x10,9q34.3(139,390,541-139,418,283)x2,1
4q32.33(106,331,956-106,850,462)x3,14q32.33(106,469,365-106,497,204)x3,15q11.1q11.2(20,399,030-22,698,581)
x3,16p11.2(32,573,808-34,363,720)x2,17q21.33(48,263,136-48,274,043)x2,22q11.21(19,707,321-19,716,812)x2,2
2q11.22(23,056,562-23,244,636)x10,22q13.32(48,655,121-48,771,433)x1
arr Xp22.33p11.1(2,695,374-58,543,823)
x1,Xq11.1q28(61,934,507-155,102,406)x1
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Table IV:  CGH+SNP findings and subjects with abnormal karyotype
ID After Germline Exclusion Karyotype
S08
arr 4p16.3p11(12,440-49,505,025)x3,4q11q35.2(52,672,433-190,466,045)x3,8p23.
3p11.1(194,625-43,727,674)x3,8q11.1q24.3(46,924,418-146,293,435)x3
48, XX, +4, +8 [13]
S17 arr 1p31.1p21.2(70,314,219-102,056,219)x1 46, XY, t(11;20)(p15;p11.2) [26]
S23 arr Xp22.33p11.1(2,695,374-58,246,917)x1,Xq11.1q28(61,934,507-155,102,406)x1
45, X, t(8;21)(q22;q22), der(4)
dup(4q?) [12].
S30
arr Yq11.21q11.223(13,675,923-22,550,312)x1,3p26.3p11.1(68,644-90,489,421)x1
,3q11.1q29(93,538,467-197,840,323)x1,3q13.13q21.2(111,119,902-125,370,235)
x1,5q14.3q35.3(85,701,372-180,696,806)x1,7p22.3p12.1(65,558-53,303,719)
x1,7p22.3p21.3(90,167-8,717,542)x1,7p21.3p21.1(10,649,696-16,535,901)x1,7p1
4.3p12.3(34,145,878-47,097,701)x1,7p12.3p12.1(48,050,043-53,303,719)x1,7q21
.11q36.3(85,765,132-159,075,079)x1,9p22.3p21.3(16,375,027-21,584,042)x3,9p1
3.3p13.1(34,556,560-40,719,201)x1,12p13.33p13.31(1,176,383-8,291,515)x3,12p
13.33p13.31(2,704,800-8,048,500)x4,13q11q12.3(19,149,060-30,342,672)x3,13q1
1q12.13(19,227,564-26,035,359)x3,13q12.3q31.1(30,404,904-87,111,281)x1
42,XY,-3,del(5)(q12q33),-
7,der(12)t(3;12)(p14;p12),-
13,-14,der(19)t(19;?)(q12.3;?)
[7]/43,idem,+mar[10]/44,idem,
+mar,+mar[8]
S31
arr 7q22.1q36.3(100,780,826-158,923,949)x1,11p15.5p11.12(192,358-51,538,651)
x3,11q11q25(54,909,688-134,934,196)x3,17p13.3p13.1(44,684-7,572,867)x1,17p1
2p11.2(13,236,413-22,128,401)x1
46, XX, t(11;17)(q13;p11.2), 
der(21)add(21)(q22) [22]
S33 arr 9q21.11q31.1(71,046,033-103,362,618)x1
46, XX, t(8;21)(q22;q22), del(9)
(q22) [8]
S36 arr 5q14.3q34(83,525,460-162,507,695)x1
46,XX, del(5)(p13) [18] / 46, 
XX [4]
S37 arr(1-22,X)x2
46,XX, t(13;15;17)(q21;q24;q21) 
[15]
S39
arr Xp22.33p11.1(2,695,374-58,543,823)x1,Xp22.2p21.3(10,715,887-25,472,209)x1,X-
q11.1q28(61,781,601-155,102,406)x1
45,X,-X, t(8;21)(q22;q22) [30]
with the conventional karyotyping  method which are 
dependent on cell growth, mitotic index of the dividing 
cells and  analysable chromosome spread  but array 
CGH+SNP are not dependant on any of these factors 
as  the starting material for the array CGH+SNP is DNA. 
There is no necessity to have the karyotypes for all cases 
as the array CGH+SNP findings complements each other 
as the SNP probes in the designs aids in the confirmation 
of  CGH probes in this study except for the identification 
of translocation which are not possible using our array 
design. 
Upon comparison with other studies of the AML 
genome using array CGH and SNP platforms. (Table 
V), our team found that only several aberrations were 
recurrent (7.3%) and they displayed a low frequency 
(<5.5%). Low burden of CNVs were also observed in 
our cases, supported by previous reports (11, 12) where 
they have reported similar findings in AML where 
lower frequencies of CNVs are seen compared to 
other subtypes of leukaemia. These findings, however, 
are distinct from reports by Mehrotra et al (2014) and 
Jun et al (2014) where they discovered over two-fold 
of CNVs in their studies. Studies by Mehrotra et al and 
Jun et al lacked systematic use of germline DNA and 
so there could be over estimation of somatic CNVs 
(13,14). Based on Table III of this study, we have clearly 
shown that the use of germline DNA is one of the critical 
procedure in the assessment of an AML genome to 
distinctly determine somatic CNVs from the germline 
CNVs. Matched germline in this study revealed that most 
of the CNVs seen may not have been directly related to 
the pathogenesis of AML.  The systemic application of 
matched tumour and germline samples equipped our 
study with unequivocal delineation of somatic genetic 
alteration including CNVs and CN-LOHs, which led to 
the exclusion of CNVs and CN-LOHs from our analysis 
which in turn generated lower numbers of genomic 
aberrations in our study.
As opposed to Mehrotra et al (2014), who included 
microdeletion in kilo base pairs of unknown significance, 
we focussed our analysis on somatic genomic alterations 
above 5 Mb in size based on our SNP probe resolution 
(13) as SNP probes were utilized to confirm the CGH 
probes findings.   We discovered 419 somatic CNVs 
below 5 Mb in this study which was confirmed by a 
subsequent study with larger cohort of patient samples 
with similar disease condition (15)
Walter and his team reported 201 CNVs (35 kb to 200 
Mb), in which about 88 CNVs were below 5 Mb. Their 
sample size was 86 AML cases compared to 41 AML 
cases in this study. They performed paired analysis of 
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X as a sole recurring chromosomal abnormality were 
available; with none specific for AML. Monosomy X 
as a sole recurring abnormality was reported in other 
haematological malignancies including myelodysplastic 
syndrome and acute lymphoblastic leukaemia (18, 19). 
A study on cytogenetic profile in Iranian AML patients 
reported that Monosomy X was seen in two patients 
but no details if it was a sole recurrent abnormality or 
concurrent with other chromosomal aberrations (20).
Trisomy 4 was the most frequent and recurrent 
chromosomal gain detected in this study. Trisomy 4 
was the only abnormality detected in case S14 whereas 
in case S08, which coexisted with Trisomy 8.  As the 
only chromosomal aberration detected in S14, trisomy 
4 in AML is uncommon and the consequences are also 
unknown (21,22). Two probable candidate genes were 
identified: PDGFRA, KIT. Some studies on Trisomy 
4 have focussed on KIT mutations to study its role in 
leukopoiesis.  Their findings support that there is an 
association between trisomy 4 and overexpression of KIT 
in leukemic cells (23, 24). This could have potentially 
led to deregulated expression and proliferation capacity 
of the cells. Rearrangement of PDGFRA was associated 
with AML in other studies (25). We did not perform 
mutational analysis on KIT and PDGFRA and so we 
are unable to assess the role of these genes in the 
leukopoiesis of AML. 
We also found interesting regions of UPD/CN-LOH 
in two cases occurring in q arm of chromosome 4. In 
case S24, seven segmental stretches of CN-LOH were 
Table V: Comparison of findings from various studies with this study
Akagi et al (2009) 
[14]
Mehrotra et al 
(2014) [12]
Walter et al (2009) 
[10]
Jun et al (2011) 
[13]
This Study
Number of patients 38 48 86 133 41
Array type 250K SNP Custom 44K oligo-
nucleotide genomic 
array
SNP 6.0 SNP 6.0 Custom CGH+SNP 
180K
Cases 30 AML-NK, 8 MDS AML 60 de novo AML 133 AML-NK 41 AML
Use of Germline 0 0 60 0 41
CNVs 19 cases had one or 
more CNVs
170 total chromo-
somal aberrations 
(including mi-
crodeletion)
201 CNVs Total 113 SNP 
lesions
55 CNVs
Gains Deletion and dupli-
cation in 9 patients
71 201 CNVs 23 15
Loss 99 55 28
CN-LOH 12 patients - 8 regions of
UPD in 7 of 86 
samples
35 12 
Normal karyotype by CGH 
and/or SNP
19 patients 21 43 90 22
One or more genomic 
aberrations by CGH and/
or SNP
18 patients 27 38 43 19
tumour and germline DNA and validated their findings 
using a high resolution custom NimbleGen CGH 12X135 
array including CNVs of smaller than one Mb (11). Our 
study utilised lower resolution of array CGH+SNP and 
so the number of CNVs seen were fewer. 
Losses were more frequently seen in chromosome 7 
where CGH+SNP revealed heterogeneous breakpoints 
in three cases. In case S30, segmental deletion of p arm 
that included five breakpoints: 7p12.3 - p12.1, 7p21.3 - 
p21.1, 7p22.3 - p21.3, 7p14.3 - p12.3, 7p22.3 - p12.1 
spanning between 5.3 Mb to 53.3 Mb, and loss of 
entire q arm of chromosome 7. In case S31, segmental 
deletion of 7q22.1-q36.3 (100,780,826-158,923,949) 
was seen together with structural aberrations involving 
other chromosomes. In case S03, loss of 7q arm were 
observed as the sole chromosomal aberration. Other 
studies have reported that complete or interstitial 
deletion of chromosome 7 (-7,7q-) are non-random 
abnormalities observed in de novo AML and myeloid 
neoplasms. Region of losses identified within this study 
in the three cases encompasses 7q22 and 7q36, the 
region harbouring one or more tumour-suppressor genes 
(TSGs) inactivated in AML.  Besides that, our findings 
are in agreement with other studies which reported that 
at least three distinct loci are recurrently deleted 7q22, 
7q31.1 and 7q31.3 by allelotyping studies in AML (16, 
17).
Two cases (S23, S41) had Monosomy X as the sole 
abnormality and one case (S39) had a Monosomy X with 
t(8;21)(q22;q22) . Only sporadic reports on Monosomy 
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seen ranging from 5.3 Mb to 18.3 Mb (58,728,642-
190,449,761) in chromosome 4q. These findings 
appear to be unique to our study as we did not find any 
report with similar region of CN-LOH except in one 
study by Raghavan et al (2008) who found CN-LOH of 
chromosome 4q(87,522,823-term) in a relapsed AML 
sample (26). Although their findings were within the 
same 4q arm, it was detected in a relapsed AML sample 
and the pathogenic consequences of these aberrations 
in AML are still unknown.
We also elucidated stretches of CN-LOH in three 
different cases which were not reported elsewhere: 
patient S09 had CN-LOH in chromosome 12 q13.2 
- q14.1 (56,069,231-61,972,806); patient S05 had 
CN-LOH in chromosome 17q22 - q24.1 (57,455,620-
63,176,847); patient S26 had CN-LOH in chromosome 
18q21.2 - q21.31 (48,917,970-54,128,364). These 
regions are novel findings which could contribute 
in AML pathogenesis as the changes are only seen in 
the tumour DNA. All the four cases with CN-LOHs in 
this study were cytogenetically normal. It was reported 
that CN-LOHs are common in myeloid malignancies, 
even in cases with AML-NK. CN-LOHs have also been 
implicated with microsatellite instability in AML-NK. 
Besides that, CN-LOHs may also have homozygous 
somatic mutation where initially it was a heterozygous 
mutation duplicated through UPD that inactivates or 
totally knocks out a tumour suppressor gene such as 
TP53 in UPD17. Secondly, a double dose of mutated 
gene produced which leads to increased proliferation 
as oncogenic mutations can result through CN-LOHs (3, 
27). Since these stretches of CN-LOHs were found only 
in a few cases, assignment of prognostic significance 
will require systematic assessment of CGH+SNP in 
larger series of AML cases with investigation into the 
underlying mechanism which caused CN-LOH. 
With the use of germline DNA in this study, somatic 
lesions were successfully delineated from inherited 
sequence variants. The use of germline DNA avoided 
overestimation of genomic aberrations. Our findings do 
not agree with the opinion of Akagi et al (2009) where 
they stated that CN-LOH occurs only in the leukaemia 
samples but not in the corresponding germline DNA. 
In our study, only 22% of somatic lesions where CN-
LOHs whereas in the germline DNA about 87% were 
CN-LOHs (16). 
This further supported our claim that it is of utmost 
importance to utilise corresponding germline DNA 
in each AML case as large number of CNVs and CN-
LOHs were present as inherited sequence variants and 
are unique in each individual subject or patient. It is 
interesting to note that our CNVs and CN-LOHs that 
seen in the patients are not reported in the normal 
recurrent CNVs and CN-LOHs customised genome 
track established by Clinical Haematology Referral 
Laboratory Hospital Ampang which are established 
using normal healthy Malaysian adults (10). These could 
be due to either our CNVs are truly unique  and seen 
among our case series or the germline CNVs and CN-
LOHs could be associated in the pathogenesis of stage 
preceding leukaemic transformation of these patients or 
could be associated with clonal expansion even when 
patients have attained CR (28). However, our hypothesis 
requires another level of in depth study on a larger 
cohort with application of whole genome sequencing 
on the germline DNA and tumour DNA. Germline DNA 
should be obtained from a different source from the 
same patient such as buccal swab or tissue instead of 
the patient’s remission samples in order to accurately 
ascertain germline and somatic aberrations in future 
studies. In this study, we have limitations in terms of 
obtaining other sources of germline DNA.
CONCLUSION
In this study, we first demonstrated the advantages of 
array CGH+SNP compared to conventional karyotyping 
method which are limited in terms of resolutions, 
identification of cryptic genomic aberrations and other 
technical and sampling issues. Apart from that, we 
have distinctly exhibited the benefits of using germline 
DNAs to segregate somatic aberrations in this study. 
Array CGH+SNP holds great potential in the clinical 
setting as the results are ready in quicker turn around 
time compared to conventional method and aids 
efficient patient management. Even with the rapid 
development of other sequencing technologies, array 
CGH+SNP technology is still relevant in the diagnosis, 
prognostication and stratification of patients based on 
their genomic aberrations. 
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